Citigroup’s Biomerica BMRA Stock Holding History

Citigroup’s Portfolio BMRA Stock Details BMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$655	Buy	+290	New	+$548	﹤0.01%	5571
2026 Q1	–	Sell	-2,433	Closed	-$6.13K	–	5963
2025 Q4	$6.13K	Buy	2,433 +1,633	+204%	+$4.25K	﹤0.01%	5190
2025 Q3	$2.26K	Buy	+800	New	+$2.53K	﹤0.01%	5454

Other funds holding BMRA

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

IFG Advisory Atlanta, Georgia $3.01B AUM 18.54% 1-Year Est. Return

Larson Financial Group St Louis, Missouri $4.11B AUM 23.62% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $50.1B AUM 35.17% 1-Year Est. Return

Citigroup's BMRA Position: Q3 2026 in Review

Citigroup opened a new position in Biomerica (BMRA) in Q3 2026: 290 shares worth $655. The stake represents ﹤0.01% of the portfolio and ranks #5571 among its holdings. This is a return to the name: Citigroup previously reported a position in BMRA as recently as Q4 2025.

Citigroup first reported a position in BMRA in Q3 2025 and has held it in 3 quarters since. The position peaked at $6.13K in Q4 2025. 6 funds tracked by Wall St. Rank hold BMRA as of Q3 2026.

Citigroup held 290 shares of Biomerica worth $655 as of Q3 2026.
Biomerica was a new Citigroup position in Q3 2026.
Biomerica made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #5571 holding.
Citigroup first reported a position in Biomerica in Q3 2025 and has held it in 3 quarters since.
Citigroup's Biomerica position peaked at $6.13K in Q4 2025.
6 funds tracked by Wall St. Rank held Biomerica as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.